- Home
- APRE vs DPRO Comparison
APRE vs DPRO Comparison
Compare APRE & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- DPRO
- Stock Information
- Founded
- APRE 2006
- DPRO 1998
- Country
- APRE United States
- DPRO Canada
- Employees
- APRE N/A
- DPRO N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- DPRO Aerospace
- Sector
- APRE Health Care
- DPRO Industrials
- Exchange
- APRE Nasdaq
- DPRO Nasdaq
- Market Cap
- APRE 9.7M
- DPRO 10.4M
- IPO Year
- APRE 2019
- DPRO N/A
- Fundamental
- Price
- APRE $1.75
- DPRO $2.97
- Analyst Decision
- APRE Strong Buy
- DPRO Strong Buy
- Analyst Count
- APRE 2
- DPRO 2
- Target Price
- APRE $15.50
- DPRO $6.00
- AVG Volume (30 Days)
- APRE 35.7K
- DPRO 430.1K
- Earning Date
- APRE 05-14-2025
- DPRO 05-08-2025
- Dividend Yield
- APRE N/A
- DPRO N/A
- EPS Growth
- APRE N/A
- DPRO N/A
- EPS
- APRE N/A
- DPRO N/A
- Revenue
- APRE $1,284,475.00
- DPRO $4,716,450.00
- Revenue This Year
- APRE N/A
- DPRO $94.01
- Revenue Next Year
- APRE N/A
- DPRO $95.14
- P/E Ratio
- APRE N/A
- DPRO N/A
- Revenue Growth
- APRE 33.27
- DPRO 7.90
- 52 Week Low
- APRE $1.41
- DPRO $1.55
- 52 Week High
- APRE $5.01
- DPRO $6.75
- Technical
- Relative Strength Index (RSI)
- APRE 49.51
- DPRO 72.62
- Support Level
- APRE $1.60
- DPRO $1.69
- Resistance Level
- APRE $2.00
- DPRO $2.06
- Average True Range (ATR)
- APRE 0.16
- DPRO 0.21
- MACD
- APRE 0.02
- DPRO 0.13
- Stochastic Oscillator
- APRE 37.50
- DPRO 99.26
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.